Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease
about
How to predict clinical relapse in inflammatory bowel disease patientsPowering the immune system: mitochondria in immune function and deficiencyCytokines in the host response to Candida vaginitis: Identifying a role for non-classical immune mediators, S100 alarminsThe involvement of cholesterol in sepsis and tolerance to lipopolysaccharide highlighted by the transcriptome analysis of zebrafish (Danio rerio)Effect of the leptin receptor Q223R polymorphism on the host transcriptome following infection with Entamoeba histolytica.Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndromeAntibiotics modulate intestinal immunity and prevent necrotizing enterocolitis in preterm neonatal pigletsCorrelation between soluble triggering receptor expressed on myeloid cells-1 and endoscopic activity in intestinal Behçet's disease.A predictive model combining fecal calgranulin B and fecal occult blood tests can improve the diagnosis of colorectal cancer.Epithelial cell-derived S100 calcium-binding proteins as key mediators in the hallmark acute neutrophil response during Candida vaginitis.The role and utility of faecal markers in inflammatory bowel disease.Biomarkers of chemotherapy-induced diarrhoea: a clinical study of intestinal microbiome alterations, inflammation and circulating matrix metalloproteinases.Galectin-3 functions as an alarmin: pathogenic role for sepsis development in murine respiratory tularemia.S100A expression and interleukin-10 polymorphisms are associated with ulcerative colitis and diarrhea predominant irritable bowel syndrome.Comparison of the gene expression profiles between gallstones and gallbladder polyps.Pilot study of Biomarkers for predicting effectiveness of ramosetron in diarrhea-predominant irritable bowel syndrome: expression of S100A10 and polymorphisms of TPH1Calprotectin (S100A8/9) as serum biomarker for clinical response in proof-of-concept trials in axial and peripheral spondyloarthritisS100A8 and S100A9 induce cytokine expression and regulate the NLRP3 inflammasome via ROS-dependent activation of NF-κB(1.).Alarmin function of galectin-9 in murine respiratory tularemia.Human eosinophils express RAGE, produce RAGE ligands, exhibit PKC-delta phosphorylation and enhanced viability in response to the RAGE ligand, S100BThe epithelial danger signal IL-1α is a potent activator of fibroblasts and reactivator of intestinal inflammation.Deficiency of Nuclear Receptor Nur77 Aggravates Mouse Experimental Colitis by Increased NFκB Activity in Macrophages.S100A12 concentrations and myeloperoxidase activity in the intestinal mucosa of healthy dogs.Increased levels of calprotectin in obesity are related to macrophage content: impact on inflammation and effect of weight lossEnhanced production of early lineages of monocytic and granulocytic cells in mice with colitisActivation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs.TLR4 Endogenous Ligand S100A8/A9 Levels in Adult-Onset Still's Disease and Their Association with Disease Activity and Clinical ManifestationsS100A8/A9 proteins mediate neutrophilic inflammation and lung pathology during tuberculosisVaginal epithelial cell-derived S100 alarmins induced by Candida albicans via pattern recognition receptor interactions are sufficient but not necessary for the acute neutrophil response during experimental vaginal candidiasis.Diagnostic utility of faecal biomarkers in patients with irritable bowel syndromeS100A8/A9: a mediator of severe asthma pathogenesis and morbidity?STAT3 genotypic variation and cellular STAT3 activation and colon leukocyte recruitment in pediatric Crohn disease.Calprotectin, calgranulin C, and other members of the s100 protein family in inflammatory bowel disease.Nutriproteomics: technologies and applications for identification and quantification of biomarkers and ingredients.Colonic transcriptional profiling in resistance and susceptibility to trichuriasis: phenotyping a chronic colitis and lessons for iatrogenic helminthosis.Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications.The Role of Biomarkers in the Diagnosis and Risk Stratification of Acute Graft-versus-Host Disease: A Systematic Review.Biomarkers in acute kidney injury - pathophysiological basis and clinical performance.New Biomarkers for Diagnosing Inflammatory Bowel Disease and Assessing Treatment Outcomes.S100A9 promotes human lung fibroblast cells activation through receptor for advanced glycation end-product-mediated extracellular-regulated kinase 1/2, mitogen-activated protein-kinase and nuclear factor-κB-dependent pathways.
P2860
Q26774575-F4E9545C-A469-4C0B-A249-8F9A7B892612Q26853485-0697A6D3-5F1B-4EA8-A046-C6D15859A0A6Q27021956-2D788F16-D277-4B74-A6E9-8947285C54F8Q28468675-5BC7CFB2-ACEA-46BA-83D5-D0A5707E4BF8Q30416574-881FE905-44A7-4482-AC48-5B5EC98DF3F8Q33718699-44782F31-D825-4C86-8DD1-EC375AEB3376Q33816538-4B2CDE80-EF70-4BB1-BBCA-17F29A647037Q33822597-26167E8F-0627-4207-B8EE-C15374284BFEQ34134711-F08078FB-8B69-404D-9F54-120635CBEE92Q34309699-0F197D39-678E-46FC-A2BC-866770D09617Q34456258-733C9349-94CC-4AE1-B95D-6FD6D011F363Q34581943-21A09A7A-7F90-4A96-8764-323593A209AFQ34635334-3241F730-1FCC-4067-8613-B60CC5A1A613Q34675807-216DA6A6-51FC-4403-BF82-E95A4235020FQ34733129-1F657FE1-1397-4229-8F8A-C59170FFC3A0Q34848481-555F552F-6B62-45C5-9315-7D0184945114Q34941693-BB2FDC2A-2686-4B0B-9456-ECEEDB2ADC89Q34973392-19893473-8C00-4EB1-A599-C0A9675A57BDQ35515960-879303C0-B949-488B-8DAD-2424DCC8C418Q35579991-330BB954-A444-4DD8-83FF-C80F4D1B6B78Q35669042-8028AAD2-443C-49BF-AE9E-B58DC53E5C1DQ35737476-AA283777-E69B-4E65-AF5A-E80732ADF9C1Q35775425-BB27B655-B0AC-4AAB-B068-20C84B7F60A6Q35876768-D49883D6-5DAC-4F71-B2DA-7B10887392F7Q36339826-B0F0734C-2AB5-430C-BF95-4BFCF07BEA8AQ37153791-69682FFE-47E6-47CC-923C-253F93825F34Q37210206-81D3D800-1056-4C13-97CE-C13D92AAC1D1Q37393658-6140368A-D2B4-43F9-B3AB-84BAA1C5CF14Q37546318-9BAD520F-C735-4220-8F55-169F1D2ABBD4Q37581340-F6BEAF84-0BB6-42D9-BF72-AC1F9724ED15Q37629632-6107FBDF-8F7F-4BC6-B3B4-EF153FF4ECCFQ37718730-1E1E71F1-A49D-4D6D-9B50-CD433EFAEBCFQ37825812-BB72E532-87F7-40D0-8E37-479FF8DCE801Q37903978-552966B3-BC35-4CFC-AEE8-757526101CA3Q38505504-D5B97334-C30E-446C-99BC-96560744EFB5Q38756562-E6643ABB-D0A6-48A1-8142-9DB33BEF0C36Q38829335-7A06A3B8-0CE2-40DC-9B21-CB5D224FD003Q38836197-53F849A2-A863-401E-B577-F241FEBD6F86Q38986222-20AEF2B3-428E-4A8F-9BD7-39896DE2D95CQ39150684-B24CCCE4-834F-41CC-84D2-2D3987D00703
P2860
Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease
description
article
@en
im Oktober 2008 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2008
@uk
name
Phagocyte-specific S100 protei ...... ing inflammatory bowel disease
@en
Phagocyte-specific S100 protei ...... ing inflammatory bowel disease
@nl
type
label
Phagocyte-specific S100 protei ...... ing inflammatory bowel disease
@en
Phagocyte-specific S100 protei ...... ing inflammatory bowel disease
@nl
prefLabel
Phagocyte-specific S100 protei ...... ing inflammatory bowel disease
@en
Phagocyte-specific S100 protei ...... ing inflammatory bowel disease
@nl
P2093
P356
P1476
Phagocyte-specific S100 protei ...... ing inflammatory bowel disease
@en
P2093
H Wittkowski
J Heidemann
P2860
P304
P356
10.1002/PATH.2394
P577
2008-10-01T00:00:00Z